{"id":"azathioprine-or-mesalazine","safety":{"commonSideEffects":[{"rate":"15-30","effect":"Nausea and gastrointestinal upset"},{"rate":"5-10","effect":"Bone marrow suppression"},{"rate":"2-5","effect":"Hepatotoxicity"},{"rate":"1-3","effect":"Pancreatitis"},{"rate":"10-20","effect":"Headache"},{"rate":"5-10","effect":"Rash"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Azathioprine is a purine analog that suppresses T-cell mediated immunity by inhibiting DNA synthesis in lymphocytes. Mesalazine (5-aminosalicylic acid) acts locally in the colon to reduce inflammation through inhibition of NF-κB and production of anti-inflammatory mediators. Together they target both immune suppression and local mucosal inflammation in IBD.","oneSentence":"This is a combination therapy study comparing azathioprine (an immunosuppressant) and mesalazine (an anti-inflammatory) for inflammatory bowel disease.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:03:17.058Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory bowel disease (Crohn's disease or ulcerative colitis)"},{"name":"Induction and maintenance of remission in IBD"}]},"trialDetails":[{"nctId":"NCT05213234","phase":"NA","title":"Chronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2021-07-09","conditions":"Ulcerative Colitis","enrollment":32},{"nctId":"NCT03323476","phase":"PHASE3","title":"Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Departemental Vendee","startDate":"2018-02-02","conditions":"Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, End Stage Renal Disease","enrollment":136},{"nctId":"NCT05043870","phase":"PHASE4","title":"Combined Immunosuppression for Pediatric Crohn's Disease","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2022-10-10","conditions":"Crohn Disease, Infliximab, Immunosuppression","enrollment":128},{"nctId":"NCT07290803","phase":"","title":"This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-11-17","conditions":"Atopic Dermatitis","enrollment":1000},{"nctId":"NCT05986136","phase":"PHASE2, PHASE3","title":"Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2023-08-20","conditions":"Inflammatory Bowel Diseases","enrollment":50},{"nctId":"NCT07271069","phase":"","title":"Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2026-01-29","conditions":"Ulcerative Colitis (UC)","enrollment":150},{"nctId":"NCT07424040","phase":"NA","title":"The Efficacy and Safety of Infliximab Combination With Azathioprine in Crohn's Disease in Children","status":"NOT_YET_RECRUITING","sponsor":"The Children's Hospital of Zhejiang University School of Medicine","startDate":"2026-03-01","conditions":"Crohn's Diseases, Crohn's Disease in Pediatric Patient","enrollment":154},{"nctId":"NCT04095663","phase":"NA","title":"Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Washington","startDate":"2019-10-01","conditions":"Diverticulitis","enrollment":255},{"nctId":"NCT03656926","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":169},{"nctId":"NCT06335160","phase":"NA","title":"Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine","status":"RECRUITING","sponsor":"Tanta University","startDate":"2024-04-20","conditions":"Ulcerative Colitis","enrollment":46},{"nctId":"NCT07389824","phase":"NA","title":"Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis.","status":"NOT_YET_RECRUITING","sponsor":"Qin Yu","startDate":"2026-02-01","conditions":"Ulcerative Colitis","enrollment":80},{"nctId":"NCT06941376","phase":"PHASE2","title":"An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-08-01","conditions":"Relapsing Polychondritis","enrollment":20},{"nctId":"NCT05689879","phase":"PHASE3","title":"Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-03-23","conditions":"Sarcoidosis","enrollment":90},{"nctId":"NCT04182984","phase":"","title":"TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2019-11-04","conditions":"Ocular Myasthenia Gravis","enrollment":200},{"nctId":"NCT07333716","phase":"PHASE2","title":"Desloratadine in Patients With Ulcerative Colitis","status":"RECRUITING","sponsor":"Tanta University","startDate":"2026-01-26","conditions":"Ulcerative Colitis (UC), Ulcerative Colitis","enrollment":44},{"nctId":"NCT07077486","phase":"PHASE4","title":"Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2025-08-25","conditions":"Lupus or SLE, Interstitial Lung Disease, Systemic Lupus Erythematosus","enrollment":100},{"nctId":"NCT04259138","phase":"PHASE4","title":"Determination of the Optimal Treatment Target in Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alimentiv Inc.","startDate":"2020-02-18","conditions":"Colitis, Ulcerative","enrollment":672},{"nctId":"NCT02081755","phase":"PHASE4","title":"Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer","status":"ENROLLING_BY_INVITATION","sponsor":"Baylor Research Institute","startDate":"2014-03","conditions":"Carcinoma, Hepatocellular","enrollment":336},{"nctId":"NCT02939573","phase":"PHASE2","title":"A Randomized Multicenter Study for Isolated Skin Vasculitis","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2017-01-01","conditions":"Primary Cutaneous Vasculitis, Cutaneous Polyarteritis Nodosa, IgA Vasculitis","enrollment":90},{"nctId":"NCT07352566","phase":"PHASE4","title":"Utilization of a Microdevice for Psoriasis and Atopic Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-01-01","conditions":"Psoriasis, Atopic Dermatitis","enrollment":10},{"nctId":"NCT07349472","phase":"PHASE2","title":"Pentoxifylline in Patients With Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"Ihab Elsayed Hassan","startDate":"2026-01-20","conditions":"Inflammatory Bowel Diseases","enrollment":60},{"nctId":"NCT02807103","phase":"PHASE3","title":"Rituximab in Eosinophilic Granulomatosis With Polyangiitis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-12-05","conditions":"Eosinophilic Granulomatosis With Polyangiitis (EGPA)","enrollment":107},{"nctId":"NCT06136767","phase":"","title":"Registry for Systemic Eczema Treatments","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-01-17","conditions":"Atopic Dermatitis","enrollment":400},{"nctId":"NCT07296315","phase":"PHASE2","title":"Confirmatory Clinical Study in Active Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"MRM Health NV","startDate":"2026-03","conditions":"Colitis, Ulcerative","enrollment":204},{"nctId":"NCT07235904","phase":"PHASE4","title":"Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis","status":"RECRUITING","sponsor":"University Hospital Schleswig-Holstein","startDate":"2025-12-05","conditions":"Ulcerative Colitis (UC)","enrollment":300},{"nctId":"NCT05969730","phase":"NA","title":"Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis","status":"COMPLETED","sponsor":"Mazandaran University of Medical Sciences","startDate":"2023-08-15","conditions":"Atopic Dermatitis","enrollment":40},{"nctId":"NCT04745728","phase":"PHASE3","title":"Different Immunosuppressive Treatment in iMN","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2021-04-14","conditions":"Idiopathic Membranous Nephropathy","enrollment":200},{"nctId":"NCT03760003","phase":"PHASE2","title":"Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis","status":"COMPLETED","sponsor":"Abivax S.A.","startDate":"2019-08-13","conditions":"Ulcerative Colitis","enrollment":355},{"nctId":"NCT07168161","phase":"PHASE3","title":"BDB-001 Phase III Trial in ANCA-Associated Vasculitis","status":"RECRUITING","sponsor":"Staidson (Beijing) Biopharmaceuticals Co., Ltd","startDate":"2025-11-10","conditions":"ANCA Associated Vasculitis (AAV)","enrollment":300},{"nctId":"NCT06998693","phase":"","title":"A Single-Center Observational Study on the Impact of Symptom Assessment Timing on the Short-Term Efficacy of 5-ASA Therapy in Patients With Initial-Onset or Relapsed Mild-to-Moderate Active Ulcerative Colitis","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2024-08-01","conditions":"Ul","enrollment":180},{"nctId":"NCT07248644","phase":"PHASE4","title":"Discontinuation of Thiopurine Therapy in Elderly Patients With Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa","startDate":"2026-03-01","conditions":"Ulcerative Colitis (UC)","enrollment":304},{"nctId":"NCT00748644","phase":"PHASE3","title":"Efficacy Study of Two Treatments in the Remission of Vasculitis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-10","conditions":"Wegener Granulomatosis, Microscopic Polyangiitis","enrollment":117},{"nctId":"NCT03164473","phase":"PHASE3","title":"Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-03-07","conditions":"Eosinophilic Granulomatosis With Polyangiitis","enrollment":98},{"nctId":"NCT05030155","phase":"PHASE3","title":"Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-05-30","conditions":"Eosinophilic Granulomatosis With Polyangiitis","enrollment":100},{"nctId":"NCT07064707","phase":"PHASE2","title":"Rupatadine in Patients With Ulcerative Colitis","status":"RECRUITING","sponsor":"Alexandria University","startDate":"2025-07-15","conditions":"Ulcerative Colitis","enrollment":60},{"nctId":"NCT06201793","phase":"PHASE2","title":"Minocyclin in Ulcerative Colitis as Added on Therapy","status":"COMPLETED","sponsor":"Mostafa Bahaa","startDate":"2024-01-22","conditions":"Inflammatory Bowel Diseases","enrollment":46},{"nctId":"NCT06881927","phase":"PHASE4","title":"Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2026-02-01","conditions":"Sepsis and Septic Shock, Acute Respiratory Failure, Kidney Transplant Recipients","enrollment":212},{"nctId":"NCT05567068","phase":"PHASE2","title":"Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-02-01","conditions":"Inflammatory Bowel Diseases","enrollment":54},{"nctId":"NCT04773392","phase":"PHASE4","title":"Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2021-11-23","conditions":"Kidney Transplantation, Kidney Transplant Rejection","enrollment":20},{"nctId":"NCT03657342","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":62},{"nctId":"NCT05249452","phase":"","title":"Adding Azathioprine/Hydroxyurea Preconditioning to Alemtuzumab/TBI to Reduce Risk of Graft Failure in MSD HSCT in Adult SCD Patients","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2018-03-08","conditions":"Sickle Cell Disease","enrollment":20},{"nctId":"NCT07180186","phase":"","title":"Microbiota and Probiotic Therapy in Ulcerative Colitis Patients","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-01-01","conditions":"Microbiota, Probiotic Therapy, Ulcerative Colitis","enrollment":70},{"nctId":"NCT01284725","phase":"PHASE3","title":"Weaning of Immunosuppression in Nephritis of Lupus","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2011-02-16","conditions":"Nephritis of Lupus","enrollment":100},{"nctId":"NCT00647166","phase":"PHASE3","title":"Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-05","conditions":"MPA, PAN or EGPA With FFS=0, At Diagnosis or Within the First 15 Days Following Initiation of Corticosteroids","enrollment":114},{"nctId":"NCT06673134","phase":"","title":"Prospective Cohort Establishment and Clinical Observation of Children With Crohn's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tongji Hospital","startDate":"2023-12-01","conditions":"Crohn Disease","enrollment":100},{"nctId":"NCT07138898","phase":"PHASE2","title":"Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty","status":"NOT_YET_RECRUITING","sponsor":"NYU Langone Health","startDate":"2025-09","conditions":"Rheumatic Disease","enrollment":80},{"nctId":"NCT06476366","phase":"EARLY_PHASE1","title":"Comparison of Efficacy of Methotrexate and Azathioprine in Patients With Chronic Actinic Dermatitis: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Pak Emirates Military Hospital","startDate":"2024-07-14","conditions":"Chronic Actinic Dermatitis","enrollment":20},{"nctId":"NCT05646992","phase":"PHASE2, PHASE3","title":"Uterus Transplantation to Treat Infertility","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-03-01","conditions":"Uterine Factor Infertility","enrollment":40},{"nctId":"NCT04362293","phase":"PHASE2","title":"Reduced Intensity Transplantation for Severe Sickle Cell Disease","status":"SUSPENDED","sponsor":"St. Jude Children's Research Hospital","startDate":"2020-04-30","conditions":"Sickle Cell Disease","enrollment":40},{"nctId":"NCT05316220","phase":"PHASE3","title":"A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis","status":"WITHDRAWN","sponsor":"AbbVie","startDate":"2025-09-15","conditions":"Ulcerative Colitis (UC)","enrollment":""},{"nctId":"NCT05988528","phase":"PHASE2, PHASE3","title":"Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis","status":"COMPLETED","sponsor":"Mostafa Bahaa","startDate":"2023-08-20","conditions":"Inflammatory Bowel Diseases","enrollment":50},{"nctId":"NCT05561062","phase":"PHASE2","title":"Atorvastatin in Patients With Ulcerative Colitis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-12-01","conditions":"Inflammatory Bowel Diseases","enrollment":50},{"nctId":"NCT04972760","phase":"PHASE3","title":"Baricitinib in Patients With Relapsing or naïve Dermatomyositis","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-08-31","conditions":"Dermatomyositis","enrollment":62},{"nctId":"NCT05558761","phase":"PHASE2","title":"Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-10-10","conditions":"Inflammatory Bowel Diseases","enrollment":50},{"nctId":"NCT01461837","phase":"PHASE2","title":"Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"New York Medical College","startDate":"2012-01","conditions":"Sickle Cell Disease","enrollment":21},{"nctId":"NCT03414502","phase":"PHASE3","title":"Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response","status":"RECRUITING","sponsor":"University of Nebraska","startDate":"2007-12-10","conditions":"Rheumatoid Arthritis","enrollment":400},{"nctId":"NCT06243068","phase":"NA","title":"Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial","status":"ENROLLING_BY_INVITATION","sponsor":"George Washington University","startDate":"2024-11-13","conditions":"Chronic Kidney Disease","enrollment":3000},{"nctId":"NCT05237323","phase":"PHASE3","title":"Micophenolate Mofetil Versus Azathioprine in Myocarditis","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2020-10-01","conditions":"Lymphocytic Myocarditis (Disorder), Heart Failure, Dilated Cardiomyopathy","enrollment":50},{"nctId":"NCT06903130","phase":"","title":"Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sNfL) and Glial Fibrillary Acidic Protein (sGFAP) Levels in Patients With Aquaporin-4-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)","status":"NOT_YET_RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2025-09-01","conditions":"NMOSD","enrollment":40},{"nctId":"NCT07044141","phase":"PHASE1","title":"Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lahore General Hospital","startDate":"2025-03-01","conditions":"Vitiligo","enrollment":20},{"nctId":"NCT05663775","phase":"PHASE2","title":"Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2024-08-20","conditions":"Immune-related Adverse Event, Diarrhea, Advanced Melanoma","enrollment":20},{"nctId":"NCT06993974","phase":"PHASE2","title":"Nitazoxanide in Patients With Ulcerative Colitis","status":"RECRUITING","sponsor":"Alexandria University","startDate":"2025-05-30","conditions":"Ulcerative Colitis","enrollment":70},{"nctId":"NCT07032337","phase":"","title":"Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2011-01-01","conditions":"Neuromyelitis Optica Spectrum Disorder (NMOSD)","enrollment":2985},{"nctId":"NCT07012239","phase":"","title":"The Frequency of Thiopurine Methyltransferase Polymorphism in Systemic Lupus Erythematosus SLE","status":"COMPLETED","sponsor":"Bangladesh Medical University","startDate":"2016-01-01","conditions":"Genetic Polymorphism","enrollment":348},{"nctId":"NCT06878495","phase":"NA","title":"Efficacy and Safety of Discontinuing 5-ASA in Patients With Inflammatory Bowel Disease","status":"NOT_YET_RECRUITING","sponsor":"Pusan National University Hospital","startDate":"2025-06-15","conditions":"Ulcerative Colitis (UC), Crohn's Disease, Inflammatory Bowel Disease (IBD)","enrollment":100},{"nctId":"NCT05040464","phase":"PHASE3","title":"Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2021-08-26","conditions":"Crohn Disease, Azathioprine, Methotrexate","enrollment":166},{"nctId":"NCT03261206","phase":"PHASE4","title":"Stopping Aminosalicylate Therapy in Inactive Crohn's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alimentiv Inc.","startDate":"2017-11-20","conditions":"Crohn Disease, Remission","enrollment":334},{"nctId":"NCT03828019","phase":"PHASE3","title":"Adalimumab vs. Conventional Immunosuppression for Uveitis Trial","status":"COMPLETED","sponsor":"JHSPH Center for Clinical Trials","startDate":"2019-09-16","conditions":"Uveitis","enrollment":227},{"nctId":"NCT03681652","phase":"","title":"Post-Operative Crohn's Disease Outcome in Children","status":"RECRUITING","sponsor":"Schneider Children's Medical Center, Israel","startDate":"2019-02-11","conditions":"Crohn Disease","enrollment":100},{"nctId":"NCT05998759","phase":"PHASE2","title":"Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia","status":"RECRUITING","sponsor":"Beijing Hospital","startDate":"2023-12-02","conditions":"Connective Tissue Diseases, Thrombocytopenia","enrollment":296},{"nctId":"NCT06763848","phase":"NA","title":"Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder","status":"RECRUITING","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2025-04-25","conditions":"Neuromyelitis Optica Spectrum Disorders","enrollment":144},{"nctId":"NCT06925698","phase":"PHASE3","title":"Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease","status":"NOT_YET_RECRUITING","sponsor":"Marmara University","startDate":"2025-04-30","conditions":"Behcet Disease, Behcet Disease and Vascular Involvement, Deep Venous Thromboses","enrollment":110},{"nctId":"NCT05321758","phase":"NA","title":"Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2020-03-22","conditions":"Crohn Disease","enrollment":50},{"nctId":"NCT05553704","phase":"PHASE2","title":"Metformin in Patients With Ulcerative Colitis Treated With Mesalamine","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-11-01","conditions":"Inflammatory Bowel Diseases","enrollment":60},{"nctId":"NCT05545384","phase":"PHASE3","title":"Immediate Versus Delayed Treatment With Azathioprine or Rituximab in Anti-MOG Antibodies Associated Acute Demyelinating Syndromes in Children: a Randomized Controlled Clinical Trial","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-04","conditions":"Acute Demyelinating Syndrome","enrollment":86},{"nctId":"NCT05781698","phase":"PHASE2","title":"Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-03-20","conditions":"Inflammatory Bowel Diseases","enrollment":60},{"nctId":"NCT06895252","phase":"NA","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2025-03-15","conditions":"Ulcerative Colitis (UC)","enrollment":220},{"nctId":"NCT05753267","phase":"PHASE2, PHASE3","title":"Fenofibrate in Ulcerative Colitis","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-02-28","conditions":"Inflammatory Bowel Diseases","enrollment":60},{"nctId":"NCT05060991","phase":"PHASE4","title":"Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2021-09-24","conditions":"COVID-19, Immunosuppression, Vaccine Response Impaired","enrollment":50},{"nctId":"NCT02994927","phase":"PHASE3","title":"A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis","status":"COMPLETED","sponsor":"Amgen","startDate":"2017-03-15","conditions":"ANCA-Associated Vasculitis","enrollment":331},{"nctId":"NCT00866684","phase":"PHASE4","title":"Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol","status":"TERMINATED","sponsor":"Charite University, Berlin, Germany","startDate":"2007-01-01","conditions":"Skin Cancer","enrollment":44},{"nctId":"NCT06226662","phase":"PHASE2","title":"Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)","status":"NOT_YET_RECRUITING","sponsor":"NovelMed Therapeutics","startDate":"2026-06","conditions":"Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis","enrollment":12},{"nctId":"NCT04469842","phase":"EARLY_PHASE1","title":"Early Use of Long-acting Tacrolimus in Lung Transplant Recipients","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-12-01","conditions":"Lung Transplant; Complications","enrollment":48},{"nctId":"NCT06213857","phase":"PHASE2","title":"Beneficial Effect of Silymarin in Ulcerative Colitis","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-02-01","conditions":"Ulcerative Colitis","enrollment":44},{"nctId":"NCT05575505","phase":"PHASE2","title":"Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-02-02","conditions":"Inflammatory Bowel Diseases","enrollment":44},{"nctId":"NCT05574387","phase":"PHASE2","title":"Metformin as Added on Therapy in Patients With Ulcerative Colitis","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-01-20","conditions":"Inflammatory Bowel Diseases","enrollment":46},{"nctId":"NCT06846255","phase":"PHASE4","title":"Comparing DCP and DAP for Pemphigus Vulgaris","status":"COMPLETED","sponsor":"Jinnah Postgraduate Medical Centre","startDate":"2021-06-15","conditions":"Pemphigus Vulgaris","enrollment":66},{"nctId":"NCT03591770","phase":"PHASE4","title":"Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib","status":"TERMINATED","sponsor":"Boston Medical Center","startDate":"2019-07-31","conditions":"Inflammatory Bowel Diseases","enrollment":15},{"nctId":"NCT05119140","phase":"PHASE1, PHASE2","title":"Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2022-06-10","conditions":"Ulcerative Colitis (Disorder)","enrollment":3},{"nctId":"NCT06067698","phase":"NA","title":"Alpha Lipoic Acid in Ulcerative Colitis","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-10-01","conditions":"Ulcerative Colitis, Ulcerative Colitis (UC)","enrollment":60},{"nctId":"NCT05349006","phase":"PHASE3","title":"Azathioprine in MOGAD","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2023-12-12","conditions":"Central Nervous System Inflammation, MOG-IgG Associated Disease","enrollment":126},{"nctId":"NCT04871191","phase":"PHASE3","title":"Study of Salvage Therapy to Treat Patients with Granulomatosis with Polyangiitis","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-03","conditions":"Granulomatosis with Polyangiitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis","enrollment":42},{"nctId":"NCT02852694","phase":"PHASE4","title":"Reduce Risk for Crohn's Disease Patients","status":"COMPLETED","sponsor":"PIBD-Net","startDate":"2017-02-28","conditions":"Crohn's Disease","enrollment":192},{"nctId":"NCT05684484","phase":"PHASE4","title":"Role of Roflumilast in Ulcerative Colitis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-02-01","conditions":"Ulcerative Colitis","enrollment":52},{"nctId":"NCT03555448","phase":"PHASE4","title":"Once Daily Immunosuppression Regimen","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2018-06-04","conditions":"Kidney Transplant; Complications","enrollment":51},{"nctId":"NCT06786689","phase":"PHASE2","title":"To Compare the Efficacy of Weekly Azathioprine Pulse Versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata","status":"COMPLETED","sponsor":"Sheikh Zayed Medical College","startDate":"2023-03-01","conditions":"Alopecia Areata, Alopecia Areata(AA)","enrollment":60},{"nctId":"NCT04660539","phase":"PHASE3","title":"A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2021-03-02","conditions":"Neuromyelitis Optica Spectrum Disorder","enrollment":119},{"nctId":"NCT04106830","phase":"","title":"Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2019-01-01","conditions":"NMO Spectrum Disorder, MRI, Multiple Sclerosis","enrollment":1000},{"nctId":"NCT05780723","phase":"NA","title":"Treatment of Ulcerative Colitis With Rectal Instillation of Qinghua Quyu Prescription(QHQYP)","status":"COMPLETED","sponsor":"Beijing Hospital of Traditional Chinese Medicine","startDate":"2023-04-04","conditions":"Ulcerative Colitis","enrollment":60},{"nctId":"NCT04920149","phase":"PHASE2","title":"Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome","status":"RECRUITING","sponsor":"Ann-Sofie Backman","startDate":"2022-03-21","conditions":"Lynch Syndrome, Colon Cancer, Colon Neoplasm","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":28323,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Azathioprine OR Mesalazine","genericName":"Azathioprine OR Mesalazine","companyName":"Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives","companyId":"groupe-d-etude-therapeutique-des-affections-inflammatoires-digestives","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a combination therapy study comparing azathioprine (an immunosuppressant) and mesalazine (an anti-inflammatory) for inflammatory bowel disease. Used for Inflammatory bowel disease (Crohn's disease or ulcerative colitis), Induction and maintenance of remission in IBD.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}